Correlation between ischemia-modified albumin and lipid levels in patients with acute cerebrovascular disease

Molecular Medicine Reports

Volumn 6, Issue 3, 2012, Pages 621-624

  Han, Kun ^a   Jia, Ning ^a   Yang, Li ^a   Min, Lian Qiu ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute cerebrovascular disease; Blood lipid; Correlation; Ischemia modified album

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIA MODIFIED ALBUMIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; CEREBROVASCULAR DISORDERS; CHOLESTEROL; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 84865159885     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.961     Document Type: Article

References (23)

1. Martinez-Gonzãlez NA and Sudlow CL: Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Pshychiatry 77: 1329-1335, 2006.
2. Gong X, Fang M, Wang J, et al: Three-dimensional reconstruction of brain surface anatomy based on magnetic resonance imaging diffusion-weighted imaging: a new approach. J Biomed Sci 11: 711-716, 2004. (Pubitemid 39664223)
3. Salvarani C, Brown RD Jr, Calamia KT, et al: Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62: 442-451, 2007. (Pubitemid 350308768)
4. Wu AH: The ischemia modified albumin biomarker for myocardial ischemia. MLO Med Lab Obs 35: 36-38, 2003.
5. Sinha MK, Roy D, Gaze DC, Collinson PO and Kaski JC: Role of 'ischemia modified albumin', a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndrome. Emerg Med J 21: 29-34, 2004. (Pubitemid 38165479)
6. Sacchetti A: 'Ischemia modified albumin': a new biochemical marker of myocardial ischemia. Emerg Med J 21: 3-4, 2004.
7. Keating L, Benger JR, Beetham R, et al: The PRIM A study: presentation of ischemia modified albumin in the emergency department. Emerg Med J 23: 764-768, 2006.
8. Refaai MA, Wright RW, Parvin CA, et al: Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta 366: 264-268, 2006. (Pubitemid 43330993)
9. Turedi S, Gunduz A, Mentese, et al: The value of ischemia-modified albumin in the diagnosis of pulmonary embolism. AM J Emerg Med 25: 770-773, 2007. (Pubitemid 47385040)
10. Gunduz A, Turedi S, Mentese A, et al: Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. AM J Emerg Med 26: 202-205, 2009. (Pubitemid 351215796)
11. Gunduz A, Turedi S, Mentese A, et al: Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 26: 874-878, 2008.
12. Duarte MM, Rocha JB, Moresco RN, et al: Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 42: 666-671, 2009.
13. Valle Gottlieb MG, da Cruz IB, Duarte MM, et al: Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 95: 586-591, 2010.
14. Piva SJ, Duarte MM, Da Cruz IB, et al: Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clin Biochem 44: 345-347, 2011.
15. Velcheva I, Antonova N, Dimitrova V, et al: Plasma lipids and blood viscosity in patients with cerebrovascular disease. Clin Hemorheol Microcirc 35: 155-157, 2006. (Pubitemid 44126493)
16. Kimura Y and Uchiyama S: Hyperlipidemia and cerebrovascular disease. Nihon Rinsho 23: 685-689, 2001.
17. Moore, WS, Barnett HJ, Beebe HG, et al: Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation 91: 566-579, 1995.
18. Pappachan J and Kirkham FJ: Cerebrovascular disease and stroke. Arch Dis Child 93: 890-898, 2008.
19. Roy D, Quiles J, Sharma R, et al: Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 50: 1656-1680, 2004.
20. Lippi G, Montagnana M and Guidi GC: Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia. Int J Cardiol 108: 410-411, 2006. (Pubitemid 43339816)
21. Abboud H, Labreuche J, Meseguer E, et al: Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 23: 216-220, 2007. (Pubitemid 46239165)
22. Wei LX, Tang Q H, Sun L, et al: Relationship between oxidized lipoprotein, angiogenesis and human coronary atherosclerotic plaque stabilization. Zhonghua Bing Li Xue Za Zhi 35: 138-141, 2006.
23. Bhagavan NV, Ha JS, Park JH, et al: Utility of serum fatty acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem 55: 1588-1590, 2009.